β‑Arrestin-Mediated Activation of Chemokine Receptor CCR7 by Human β‑Defensin‑3 Drives Oral Squamous Cell Carcinoma Progression. [PDF]
Kinanti NP, Chang CC, Lai XY, Hsu HJ.
europepmc +1 more source
Discovery of a β-arrestin-biased CCKBR agonist that blocks CCKBR-dependent long-term potentiation. [PDF]
Shi H +14 more
europepmc +1 more source
An arginine switch drives the stepwise activation of β-arrestin by CXCR7. [PDF]
Ji JS +10 more
europepmc +1 more source
Pomolic acid alleviates CCl<sub>4</sub>‑induced liver fibrosis in mice by suppressing β-arrestin 2-mediated pro-fibrotic macrophage polarization. [PDF]
Zhu X +5 more
europepmc +1 more source
GPR43 alleviates LPS-induced acute lung injury by inhibiting NLRP3 inflammasome activation via β-arrestin 2. [PDF]
Wang C +8 more
europepmc +1 more source
Biased Agonists of the Type 1 Angiotensin II Receptor Promote Distinct Subcellular β-Arrestin Conformations. [PDF]
Chundi A, Pham U, Darbha S, Rajagopal S.
europepmc +1 more source
Apomorphine differentially engages the cAMP and β-arrestin signaling pathways relative to dopamine at human dopamine receptors. [PDF]
Yegla B +4 more
europepmc +1 more source
Activated protein C drives β-arrestin-2- and c-Src-dependent phosphorylation of Cav1 and modulates Cav1 association with PAR1 and GRK5. [PDF]
Qin H +6 more
europepmc +1 more source
Molecular mechanism of β-arrestin 2 interaction with phosphorylated intracellular loop 3 of dopamine receptor D2. [PDF]
Kim K +6 more
europepmc +1 more source
Exploring a novel mechanism for targeting β-arrestin-2 in the management of diabetic nephropathy. [PDF]
Liu N, Yan WT, Xiong K.
europepmc +1 more source

